268 related articles for article (PubMed ID: 23386283)
1. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems.
Su JB
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):319-28. PubMed ID: 23386283
[TBL] [Abstract][Full Text] [Related]
2. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade.
Tschöpe C; Schultheiss HP; Walther T
J Cardiovasc Pharmacol; 2002 Apr; 39(4):478-87. PubMed ID: 11904521
[TBL] [Abstract][Full Text] [Related]
3. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.
Schmaier AH
Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R1-13. PubMed ID: 12793984
[TBL] [Abstract][Full Text] [Related]
4. The renin-angiotensin and the kallikrein-kinin systems.
Campbell DJ
Int J Biochem Cell Biol; 2003 Jun; 35(6):784-91. PubMed ID: 12676165
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk of the renin-angiotensin and kallikrein-kinin systems.
Shen B; El-Dahr SS
Biol Chem; 2006 Feb; 387(2):145-50. PubMed ID: 16497145
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
[TBL] [Abstract][Full Text] [Related]
7. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017).
Igić R
Exp Eye Res; 2018 Jan; 166():74-83. PubMed ID: 28549900
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
Fang C; Schmaier AH
Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions of vasoactive systems in cardiovascular damage.
Bader M
J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S7-9. PubMed ID: 11811382
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system and its blockers.
Igić R; Škrbić R
Srp Arh Celok Lek; 2014; 142(11-12):756-63. PubMed ID: 25731011
[TBL] [Abstract][Full Text] [Related]
11. Impact of kinins in the treatment of cardiovascular diseases.
Regoli D; Plante GE; Gobeil F
Pharmacol Ther; 2012 Jul; 135(1):94-111. PubMed ID: 22537664
[TBL] [Abstract][Full Text] [Related]
12. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of the bradykinin B(2) receptor gene in mice alters the ontogeny of the renin-angiotensin system.
Yosipiv IV; Dipp S; El-Dahr SS
Am J Physiol Renal Physiol; 2001 Nov; 281(5):F795-801. PubMed ID: 11592936
[TBL] [Abstract][Full Text] [Related]
14. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
Rhaleb NE; Yang XP; Carretero OA
Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
[TBL] [Abstract][Full Text] [Related]
15. Critical insights into the beneficial and protective actions of the kallikrein-kinin system.
Regoli D; Gobeil F
Vascul Pharmacol; 2015 Jan; 64():1-10. PubMed ID: 25579779
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy.
Wilkinson-Berka JL; Fletcher EL
Curr Pharm Des; 2004; 10(27):3313-30. PubMed ID: 15544518
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.
Regoli D; Gobeil F
Can J Physiol Pharmacol; 2017 Oct; 95(10):1117-1124. PubMed ID: 28384411
[TBL] [Abstract][Full Text] [Related]
18. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-kinin system in hepatic experimental models.
Kouyoumdjian M; Nagaoka MR; Borges DR
Peptides; 2005 Aug; 26(8):1301-7. PubMed ID: 16042971
[TBL] [Abstract][Full Text] [Related]
20. What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
Naffah-Mazzacoratti Mda G; Gouveia TL; Simões PS; Perosa SR
World J Biol Chem; 2014 May; 5(2):130-40. PubMed ID: 24921004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
